Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02383732 · ClinicalTrials.gov registry record · NA
A Study of the Elopement Prevention and Safety Training Program
A NA study of Autism Spectrum Disorder and Elopement, sponsored by Emory University.
- Completed
- Registry status
- NA
- Development phase
- 24
- Enrollment target
- 1
- Study location
NCT02383732: Completed NA study of Autism Spectrum Disorder and Elopement, sponsored by Emory University.
NCT02383732 is a NA study of Autism Spectrum Disorder and Elopement that has completed, run by Emory University. The registered enrollment target is 24 participants, below the 135-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (82% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02383732, a NA study of Autism Spectrum Disorder and Elopement, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to demonstrate the feasibility of the Elopement Prevention Safety (EPST) program in children with autism spectrum disorder (ASD) who have engaged in eloping. This is a program created by the Behavior Treatment Clinics to help caregivers come up with a safety plan to prevent their children from running away or wandering off.
Primary Outcome
An independent evaluator (IE) will conduct a parent target problem survey to help caregivers estimate the frequency of elopement as well as its impact on the family. From this description, the IE (who will be blind to treatment assignment) will generate a brief narrative describing the participant's elopement. This narrative will be used by the IE to rate the overall severity on the 7-point Clinical Global Impression for Severity (CGI-S). Clinical Global Impression of Severity (CGI-S) Scale is a
Conditions Studied
Interventions
- BEHAVIORAL Universal Safety Measures Module (All participants)
- BEHAVIORAL Proximity Training Module (Bolting Prevention Participants)
- BEHAVIORAL Check-In Training Module (Wandering Prevention Participants)
Study Locations (1)
Georgia
- Marcus Autism Center - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2015-02 |
| Est. Completion | 2017-01-31 |
| Phase | NA |
What the finished NCT02383732 record still lists
NCT02383732 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 135-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (82% lower).
The record links to 2 conditions, with Autism Spectrum Disorder appearing as the primary indexed condition, and to 3 interventions - of which Universal Safety Measures Module (All participants) is the first listed.
NCT02383732 reports a single indexed study location in Georgia.
Frequently Asked Questions
What is clinical trial NCT02383732 about?
NCT02383732 is a clinical study titled "A Study of the Elopement Prevention and Safety Training Program". The purpose of this study is to demonstrate the feasibility of the Elopement Prevention Safety (EPST) program in children with autism spectrum disorder (ASD) who have engaged in eloping. This is a program created by the Behavior Treatment Clinics to help caregivers come up with a safety plan to prev...
What is the current status of trial NCT02383732?
This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2015-02. Estimated completion is 2017-01-31.
What conditions does trial NCT02383732 study?
This clinical trial studies the following conditions: Autism Spectrum Disorder, Elopement.
What interventions are being tested in trial NCT02383732?
The interventions under investigation include: Universal Safety Measures Module (All participants) (BEHAVIORAL), Proximity Training Module (Bolting Prevention Participants) (BEHAVIORAL), Check-In Training Module (Wandering Prevention Participants) (BEHAVIORAL).
Who is sponsoring clinical trial NCT02383732?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02383732 being conducted?
This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Autism Spectrum Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02383732's enrollment target sits among peer trials
24 188th of 224 higher than 31 of 224 other Autism Spectrum Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Autism Spectrum Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
COMPASS Across Settings (CAST) for Improving Transition Outcomes for Students With ASD
RECRUITING · NA
-
Emergent Multi-Class Imitation Training
RECRUITING · NA
-
Physical Activity and Community EmPOWERment Project
RECRUITING · NA
-
Online Pivotal Response Treatment Training in Autism Spectrum Disorder
RECRUITING · NA
-
Cerebellum and Autism: Regional Specialization for Social and Executive Functions
RECRUITING · NA
-
Milieu Teaching-AV (MT-AV Pilot)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia